Blog

  • Is tirzepatide an effective weight-loss treatment for adults living with obesity and does it cause unwanted effects?

    Key messages

    • Compared to placebo (a sham medication), tirzepatide likely helps adults with obesity lose weight in the medium term (up to 2 years), and this weight reduction is likely to be maintained over the long term (more than 2 years)….

    Continue Reading

  • East Yorkshire farmer says bird flu measures are becoming regular

    East Yorkshire farmer says bird flu measures are becoming regular

    A farmer has said bird flu measures are becoming the new normal for people in the poultry industry.

    The latest restrictions came into effect from 00:01 GMT on Thursday and require owners to keep their flock on a strict lockdown in their housing to…

    Continue Reading

  • Solstad Maritime ASA: Presentation of Third-Quarter 2025 Results

    Solstad Maritime ASA: Presentation of Third-Quarter 2025 Results

    30.10.2025

    Solstad Maritime ASA: Presentation of Third-Quarter 2025 Results

    Skudeneshavn, 30 October 2025

    Solstad Maritime ASA (SOMA) is pleased to present its financial results for the third quarter of 2025.

    CEO Lars Peder Solstad stated:

    “The market has shown less activity in third quarter than earlier expected. At the same time, we maintain a positive outlook for 2026, supported by steady tendering activity and a solid order backlog.”

    • Adjusted EBITDA of USD 69 million in the quarter compared to USD 91 million in the same quarter last year. USD 229 million year to date compared to USD 220 million last year.
    • Several contract extensions and new contracts entered into, contributing to a total order intake of USD 180 million in the quarter equaling a book-to-bill ratio of 1.2x
    • Continued shareholder friendly approach with a cash dividend for Q3 2025 of USD 0.032/share, totaling USD ~15 million

    Contacts

    Lars Peder Solstad CEO, at +47 91 31 85 85

    Kjetil Ramstad CFO, at +47 907 59 489

    Solstad Maritime ASA

    www.solstad-maritime.com

    This information is subject of the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

    SOMA Q3 2025 Presentation

    Continue Reading

  • ‘Binfluencer’ son helps Bury family save thousands with recycling

    ‘Binfluencer’ son helps Bury family save thousands with recycling

    Lindsey Prosser,BBC North West Tonight and

    Jenny Coleman,North West

    Glen Minikin Tommy crouched behind three recycling bins holding a cardboard cereal box. He is wearing a high visibility orange bib, red gloves and a white hard hat with Biffa written on it in red writingGlen Minikin

    Tommy was named Britain’s top ‘binfluencer’ by waste management firm Biffa

    A 13-year-old boy named “Britain’s top binfulencer” has said his family’s recycling effort…

    Continue Reading

  • BBVA to start executing the nearly €1 billion share buyback announced earlier this year

    BBVA to start executing the nearly €1 billion share buyback announced earlier this year

    BBVA shares acquired will be used to reduce share capital through their cancellation. The buyback program will end no later than February 18, 2025², or earlier if the maximum monetary amount or the maximum number of shares is reached.

    Citigroup Global Markets Europe AG will be responsible for executing the buyback on the Spanish continuous market and on European trading platforms.

    BBVA accelerates shareholder distributions

    In addition to the share buyback starting today, on November 7, BBVA shareholders will receive the bank’s highest interim dividend in history (€0.32 gross per share), for a total amount of approximately €1.8 billion.

    Furthermore, given the significant excess capital over the 12 percent CET1 ratio, BBVA’s Board of Directors recently agreed to launch another significant share buyback¹, as soon as it receives authorization from the European Central Bank (ECB).

    BBVA’s share buyback track record

    This is the third time BBVA has opted to repurchase shares as part of its ordinary shareholder remuneration. The bank repurchased shares worth €422 million against 2022 earnings, and €781 million against 2023 earnings.

    In addition, BBVA has carried out two other share buybacks considered extraordinary shareholder remuneration. The first, between 2021 and 2022, amounted to €3.16 billion—one of the largest in Europe at the time—and the second, in 2023, totaled €1 billion.

    Overall, BBVA will have executed share buybacks worth more than €6.3 billion since 2021 including the upcoming program set to begin today.

    ¹Pending approval from the governing bodies and subject to mandatory regulatory approvals.
    ² The share buy back programme will not be executed on December 24 and 31, 2025.

    Continue Reading

  • Abou Elella R, Najm HK, Balkhy H, Bullard L, Kabbani MS. Impact of bloodstream infection on the outcome of children undergoing cardiac surgery. Pediatr Cardiol. 2010;31(4):483–9.

    PubMed 

    Google Scholar 

  • Ben…

Continue Reading

  • Meet the 8 participants of Luxembourg Song Contest 2026 – Eurovision.tv

    1. Meet the 8 participants of Luxembourg Song Contest 2026  Eurovision.tv
    2. Eight artists to compete at Luxembourg Song Contest 2026  Eurovisionworld
    3. Luxembourg: 83 Songs Submitted to Luxembourg Song Contest 2026  Eurovoix
    4. Today: 🇪🇪 Eesti Laul &…

    Continue Reading

  • Surveying Atmospheric Escape from Gas Giants Orbiting F-Type Stars

    Surveying Atmospheric Escape from Gas Giants Orbiting F-Type Stars

    Why is it important to know about exoplanets having their atmospheres stripped while orbiting F-type stars? This is what a recent study submitted to *The Astronomical Journal* hopes to address as an international team of scientists…

    Continue Reading

  • Global concerns, local challenges: the alarming spread of FC428-related gonococcal strains in Nanchang City, 2021 | BMC Microbiology

    Global concerns, local challenges: the alarming spread of FC428-related gonococcal strains in Nanchang City, 2021 | BMC Microbiology

    New infections and AMR trends of N. gonorrhoeae in Nanchang, China

    As demonstrated in Supplemental Fig. 1, the incidence of reported gonorrhea cases in China remained relatively stable from 2010 to 2020, with a significant peak of 138,855 cases…

    Continue Reading

  • Low-Dose Colchicine in Patients With Type 2 Diabetes With Recent Myocardial Infarction in the Colchicine Cardiovascular Outcome Trial (COLCOT): A Systematic Review

    Low-Dose Colchicine in Patients With Type 2 Diabetes With Recent Myocardial Infarction in the Colchicine Cardiovascular Outcome Trial (COLCOT): A Systematic Review

    Continue Reading